Sign our Perjeta Now petition to get Roche, the Scottish Government and the SMC to secure a deal to make Perjeta available to breast cancer patients in Scotland.
What’s the problem?
Women with incurable breast cancer in Scotland are being cruelly denied more time to live, because they can’t get a drug called Perjeta.
Perjeta is a life changing drug that has been the standard of care in England for over four years. Its benefits are extraordinary, offering women with incurable HER 2-positive secondary breast cancer nearly 16 extra months of life on average compared to other treatments.
Women in England and Wales can get it on the NHS as a matter of course; in Scotland, they can’t. It has been rejected three times in a row by medicines approval body, the Scottish Medicines Consortium, as it is not considered cost-effective.
This means that some women could be forced to use their life-savings to pay for it or to plead for the NHS to make a special case for them. But most women will miss out on this vital life-extending drug altogether.
What’s the solution?
We’re calling for manufacturer Roche, the Scottish Government and the Scottish Medicines Consortium (SMC) to put patients’ lives first and agree a deal to make Perjeta available at a price the NHS can afford.
The fact that a deal has been reached in England and Wales proves that it is possible for Perjeta to be made available on the NHS.
Campaign success so far
Already, our campaigning has encouraged Perjeta’s manufacturer Roche to resubmit its application to the SMC. We are now waiting to hear whether the SMC will make it routinely available on the NHS in Scotland.
How can you help?
Sign our Perjeta Now petition to get Roche, the Scottish Government and the SMC to continue to do everything they can to make Perjeta available to breast cancer patients in Scotland.